HARRISBURG, Pa.—MacuLogix, Inc. has established a $25,000 MacuLogix AMD Advocacy endowed award at Pennsylvania College of Optometry/Salus University. This award will be presented annually to a graduating optometrist who has demonstrated outstanding dedication to managing patients with age-related macular degeneration. PCO/Salus was selected for this award to honor two of its graduates for their commitment to AMD diagnosis: Glenn Corbin, OD of Wyomissing Optometric Center and Gary Kirman, OD of Kirman Eye. “PCO/Salus is proud of our alumni in bringing AdaptDx Pro to their patients to assess AMD. We are thrilled to receive these funds to create an award for AMD advocacy and eager to share the technology with our students as they deliver patient care” said PCO dean Melissa Trego, OD, PhD.

As the first commercial customers of MacuLogix, Drs. Corbin and Kirman have been utilizing dark adaptation testing in their practices since 2014, starting with the original AdaptDx automated dark adaptometer. In 2020, they also became the first optometrists to use the AdaptDx Pro head-mounted dark adaptometer. Maculogix said that based on their professional and personal commitment to elevating the standard of care for age-related macular degeneration, it is presenting their alma mater with this endowment in their honor to encourage graduating optometrists to follow in their paths.
MacuLogix is also donating an AdaptDx Pro to the PCO clinic in Chestnut Hill, Pa., to provide fourth year optometry students an opportunity to utilize the latest technology before transitioning to practice.